CSPC PHARMACEUT.GR. ADR4 (F:CVGU) — Market Cap & Net Worth
Market Cap & Net Worth: CSPC PHARMACEUT.GR. ADR4 (CVGU)
CSPC PHARMACEUT.GR. ADR4 (F:CVGU) has a market capitalization of $11.04 Billion (€9.44 Billion) as of May 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #2080 globally and #438 in its home market, demonstrating a -6.38% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CSPC PHARMACEUT.GR. ADR4's stock price €3.52 by its total outstanding shares 2855612933 (2.86 Billion). Analyse cash flow conversion of CSPC PHARMACEUT.GR. ADR4 to see how efficiently the company converts income to cash.
CSPC PHARMACEUT.GR. ADR4 Market Cap History: 2021 to 2026
CSPC PHARMACEUT.GR. ADR4's market capitalization history from 2021 to 2026. Data shows growth from $10.25 Billion to $11.08 Billion (6.33% CAGR).
CSPC PHARMACEUT.GR. ADR4 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CSPC PHARMACEUT.GR. ADR4's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.25x
CSPC PHARMACEUT.GR. ADR4's market cap is 0.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.67x
CSPC PHARMACEUT.GR. ADR4's market cap is 1.67 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $10.25 Billion | $27.87 Billion | $5.61 Billion | 0.37x | 1.83x |
| 2022 | $11.56 Billion | $30.94 Billion | $6.09 Billion | 0.37x | 1.90x |
| 2023 | $9.84 Billion | $31.45 Billion | $5.87 Billion | 0.31x | 1.68x |
| 2024 | $7.21 Billion | $29.01 Billion | $4.33 Billion | 0.25x | 1.67x |
Competitor Companies of CVGU by Market Capitalization
Companies near CSPC PHARMACEUT.GR. ADR4 in the global market cap rankings as of May 4, 2026.
Key companies related to CSPC PHARMACEUT.GR. ADR4 by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #16 globally with a market cap of $862.20 Billion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #23 globally with a market cap of $547.37 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #37 globally with a market cap of $365.30 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #16 | Eli Lilly and Company | NYSE:LLY | $862.20 Billion | $963.33 |
| #17 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #23 | Johnson & Johnson | NYSE:JNJ | $547.37 Billion | $227.19 |
| #37 | AbbVie Inc | NYSE:ABBV | $365.30 Billion | $206.60 |
CSPC PHARMACEUT.GR. ADR4 Historical Marketcap From 2021 to 2026
Between 2021 and today, CSPC PHARMACEUT.GR. ADR4's market cap moved from $10.25 Billion to $ 11.08 Billion, with a yearly change of 6.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €11.08 Billion | -2.35% |
| 2025 | €11.35 Billion | +57.41% |
| 2024 | €7.21 Billion | -26.73% |
| 2023 | €9.84 Billion | -14.89% |
| 2022 | €11.56 Billion | +12.84% |
| 2021 | €10.25 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of CSPC PHARMACEUT.GR. ADR4 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.04 Billion USD |
| MoneyControl | $11.04 Billion USD |
| MarketWatch | $11.04 Billion USD |
| marketcap.company | $11.04 Billion USD |
| Reuters | $11.04 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CSPC PHARMACEUT.GR. ADR4
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining cap… Read more